With respect to South Korea, Novartis solved specified well-publicized allegations that it had made inappropriate payments to HCPs in South Korea by means of round tables and 3rd-bash health-related journals. Novartis Korea allegedly transmitted poor honoraria to HCPs for spherical tables by way of health care journals to stop compliance scrutiny,